RAYMOND JAMES & ASSOCIATES - ENCOMPASS HEALTH CORP ownership

ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 351 filers reported holding ENCOMPASS HEALTH CORP in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ENCOMPASS HEALTH CORP
ValueSharesWeighting
Q3 2023$11,077,099
+4.9%
164,936
+5.7%
0.01%0.0%
Q2 2023$10,561,685
+7.4%
155,984
-14.2%
0.01%0.0%
Q1 2023$9,834,095
+16.2%
181,776
+28.4%
0.01%
+12.5%
Q4 2022$8,464,449
+29.4%
141,522
-2.1%
0.01%
+14.3%
Q3 2022$6,539,000
-13.7%
144,570
+7.0%
0.01%0.0%
Q2 2022$7,575,000
-24.3%
135,141
-4.0%
0.01%
-12.5%
Q1 2022$10,008,000
+62.2%
140,726
+48.8%
0.01%
+60.0%
Q4 2021$6,171,000
+75.8%
94,553
+102.1%
0.01%
+66.7%
Q3 2021$3,510,000
+72.7%
46,781
+79.5%
0.00%
+50.0%
Q2 2021$2,033,000
+1.6%
26,061
+6.7%
0.00%0.0%
Q1 2021$2,001,000
-0.8%
24,433
+0.1%
0.00%0.0%
Q4 2020$2,018,000
+24.3%
24,406
-2.3%
0.00%0.0%
Q3 2020$1,623,000
+26.0%
24,979
+20.1%
0.00%0.0%
Q2 2020$1,288,000
-6.2%
20,795
-3.0%
0.00%0.0%
Q1 2020$1,373,000
-38.8%
21,442
-33.8%
0.00%
-33.3%
Q4 2019$2,243,000
+8.2%
32,377
-1.2%
0.00%0.0%
Q3 2019$2,073,000
-14.2%
32,756
-14.1%
0.00%0.0%
Q2 2019$2,415,000
-47.5%
38,120
-51.6%
0.00%
-57.1%
Q1 2019$4,596,000
-21.3%
78,704
-16.9%
0.01%
-30.0%
Q4 2018$5,841,000
-12.7%
94,664
+10.3%
0.01%0.0%
Q3 2018$6,691,000
+80.6%
85,835
+56.9%
0.01%
+66.7%
Q2 2018$3,705,000
+14.4%
54,718
-3.4%
0.01%0.0%
Q1 2018$3,238,00056,6350.01%
Other shareholders
ENCOMPASS HEALTH CORP shareholders Q1 2018
NameSharesValueWeighting ↓
Iron Triangle Partners LP 396,670$27,477,0007.28%
Endurant Capital Management LP 163,092$11,297,0003.56%
REINHART PARTNERS, LLC. 656,158$45,452,0003.34%
RK Capital 117,590$8,145,0003.05%
HIGH POINTE CAPITAL MANAGEMENT LLC 27,150$1,881,0002.23%
Wolf Group Capital Advisors 47,461$3,288,0002.16%
Copeland Capital Management, LLC 631,346$43,734,0001.92%
Advantage Alpha Capital Partners LP 100,722$6,977,0001.88%
Rock Springs Capital Management LP 815,000$56,455,0001.78%
Kalos Management, Inc. 61,180$4,237,0001.54%
View complete list of ENCOMPASS HEALTH CORP shareholders